![](img/space.gif) |
Pharmacodynamic and molecular genetic investigation of the treatment and biological backround of psychiatric disorders
|
Help
Print
|
Here you can view and search the projects funded by NKFI since 2004
Back »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
List of publications |
|
|
Cimmer C; Csifcsák G; Szendi I; Szekeres G; Kovács ZA; Juhász A; Rimanóczy Á; Boda K; Kéri S; Janka Z: A katekol-O-metiltranszferáz (COMT) val158met polimorfizmusa és a szkizofrénia defic szindrómájának kapcsolata, p. 26 in Psychiatr Hung, Budapest, január 27-30, 2005 | Juhász A; Rimanóczy Á; Fehér Á; Kálmán J; Gálfi M; Janka Z: Alpha7 nicotinic acetylcholine receptor and apolipoprotein E polymorphisms in Alzheimer’s dementia, p S533 in Eur Neuropsychopharmacol Vienna, October 13-17, 2007 | Must A; Juhász A; Szekeres G; Rimanóczy Á; Mark AG; Myers EC; Janka Z; Kéri S: Az agyi eredetű növekedési faktor (BDNF) C270T polimorfizmusának kapcsolata a kategorizációs funkciókkal schizophreniában, p. 87. in Cephalalg Hung, Szeged, október 13-15, 2005 | Juhász A; Rimanóczy Á; Horváth Z; Zana M; Bjelik A; Rakonczay Z; Kálmán J; Janka Z: Butirilkolineszteráz-K polimorfizmus vizsgálata vascularis dementiában, p.37 in Neuropsychopharmacol Hung VII. Suppl. 1 Tihany, október 6-8, 2005 | Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z: Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?, Psychol Med 35: 1445-1455, 2005 | Juhász A; Rimanóczy Á; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J: CYP46 T/C Polymorphism is not associated with Alzheimer’s Dementia in a Population from Hungary, Neurochem Res 30(5): 943-948, 2005 | Kelemen O; Erdélyi R; Pataki I; Benedek G; Janka Z; Kéri S: Theory of mind and motion perception in schizophrenia, Neuropsychology, 19(4): 494-500, 2005 | Kéri S; Nagy O; Kelemen O; Myers CE; Gluck MA: Dissociation between medial temporal lobe and basal ganglia memory systems in schizophrenia, Schizoph Res 77: 321-328, 2005 | Kéri S; Gulyás B; Benedek G; Janka Z: Feature uncertainty: a novel test to probe prefrontal dysfunction in unaffected siblings of schizophrenia patients, Neurosci Lett 375: 33-36, 2005 | Kéri S; Kelemen O; Janka Z; Benedek G: Visual-perceptual dysfunctions are possible endophenotypes of schizophrenia: Evidence from the psychophysical investigation of magnocellular and parvocellular pathways, Neuropsychology 19(5): 649-656, 2005 | Juhász A; Rimanóczy Á; Zana M; Bjelik A; Kálmán J; Gálfi M; Janka Z: Cholesterol 24-hydroxylase and apolipoprotein E gene polymorphisms in Alzheimer’s disease in Hungarian population, p.S609 in Eur Neuropsychopharmacol15:Suppl.3 Amsterdam, October 22-26, 2005 | Juhász A; Rimanóczy Á; Zana M; Bjelik A; Kálmán J; Janka Z: Genetikai polimorfizmus vizsgálatok Alzheimer dementiában, p. 88 in Cephalalg Hung, Szeged, október 13-15, 2005 | Kálmán J; Palotás M; Pákáski M; Hugyecz M; Janka Z; Palotás A: Unchanged rat brain amyloid precursor protein levels after exposure to benzodiazepines in vivo, Eur J Anaesthesiol 23: 772-775, 2006 | Szendi I; Kiss M; Racsmány M; Boda K; Cimmer C; Vörös E; Kovács ZA; Szekeres G; Galsi G; Pléh C; Csernay L; Janka Z: Correlations between clinical symptoms, working memory functions and structural brain abnormalities in men with schizophrenia, Psychiatry Res 147: 47-55, 2006 | Cimmer C; Szendi I; Csifcsák G; Szekeres G; Kovács ZA; Somogyi I; Benedek G; Janka Z; Kéri S: Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry 30: 1225-1230, 2006 | Kálmán J; Juhász A; Bogáts G; Babik B; Rimanóczy Á; Janka Z; Penke B; Palotás A: Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary bypass surgery are predictors of cognitive decline, Neurochem Int 48: 177-180, 2006 | Fazekas I; Szakács R; Mihály A; Zador Z; Krisztin-Peva B; Juhász A; Janka Z: Alterations of seizure-induced c-fos immunolabelling and gene expression in the rat cerebral cortex following dexamethasone treatment, Acta Histochem 108: 463-73, 2006 | Hartai Z; Juhász A; Rimanóczy Á; Janáky T; Donkó T; Dux L; Penke B; Tóth G; Janka Z; Kálmán J: Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease, Neurochem Int 50: 308-13, 2006 | Juhász A; Rimanóczy Á; Kéri S; Cimmer C; Szekeres G; Szendi I; Janka Z: The C270T and Val/Met polymorphisms of brain-derived neurotrophic factor in schizophrenia, p. S213 in Eur Neuropsychopharmacol Suppl 16, Paris, September 16-20, 2006 | Szendi I; Szekeres G; Cimmer C; Csifcsák G; Kovács ZA; Juhász A; Rimanóczy Á; Boda K; Janka Z: A dopaminerg neurotranszmisszió és a neurális integritás specifikus genetikai vonatkozásainak vizsgálata a szkizofrénia neurokognitív alcsoportosításában, p.3 in Psychiatr Hung, Budapest 2006. február 1-4, 2006 | Juhász A; Rimanóczy Á; Fehér Á; Szekeres G; Kéri S; Szendi I; Cimmer C; Janka Z: Agyi eredetű neurotrofikus faktor (BDNF) val66met polimorfizmus vizsgálata szkizofréniában, p.139 in Psychiatr Hung, Budapest, február 1-4, 2006 | Kéri S; Benedek G; Janka Z: Vernier threshold and the parallel visual pathways in bipolar disorder: A follow-up study, Prog Neuropsychopharmacol Biol Psychiatry 31: 86-91, 2007 | Vincze G; Álmos P; Boda K; Döme P; Bódi N; Szlávik G; Maglóczki E; Pákáski M; Janka Z; Kálmán J: Risk factors of cognitive decline in residential care in Hungary, Int J Geriatr Psychiatry 22: 1208-1216, 2007 | Ambrus L; Juhász A; Boncz I; Temesváry B; Janka Z: Öngyilkos magatartás genetikai háttere: triptofán hidroxiláz, pp. 66-67 in Cephalalg Hung, Szeged, október 13-15, 2005 | Ambrus L; Juhász A; Godó G; Rimanóczy Á; Boncz I; Temesváry B; Janka Z: Impulzív és agresszív vonások összefüggése a triptofán hidroxiláz A218C génpolimorfizmusával öngyilkosságot megkísérelt személyeknél, p. 4 in Psychiatr Hung, Budapest, január 27-30, 2005 | Juhász A; Rimanóczy Á; Szekeres G; Kéri S; Janka Z: Serotonin A2 receptor gene T102C polymorphism and the response to treatment with second generation antipsychotics in schizophrenia, p. S138 in Eur Neuropsychopharmacol 15: Suppl. 2 Moscow April 14-16, 2005 | Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy Á; Zana M; Csont T; Pákáski M; Boda K; Ferdinándy P; Dux L; Janka Z; Sántha M: Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis, Neurochem Int 49: 393-400, 2006 | Kiss I; Janka Z; Benedek G; Kéri S: Spatial frequency processing in schizophrenia: trait or state marker?, J Abnorm Psychol 115(3): 636-638, 2006 | Must A; Szabó Z; Bódi N; Szász A; Janka Z; Kéri S: Sensitivity to reward and punishment and the prefrontal cortex in major depression, J Affect Disord 90: 209-215, 2006 | Zana M; Juhász A; Rimanóczy Á; Bjelik A; Baltás E; Ocsovszki I; Boda K; Penke B; Dobozy A; Kemény L; Janka Z; Kálmán J: Alzheimer's lymphocytes are resistant to ultraviolet B-induced apoptosis, Neurobiol Aging 27: 831-834, 2006 | Zana M; Szécsényi A; Cibula Á; Bjelik A; Juhász A; Rimanóczy Á; Szabó K; Vetró Á; Szűcs P; Várkonyi A; Pákáski M; Boda K; Raskó I; Janka Z; Kálmán J: Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes, Biochem Biophys Res Commun 345: 726-733, 2006 | Kálmán J; Bjelik A; Hugyecz M; Timár J; Gyarmati Z; Zana M; Fürst Z; Janka Z; Rakonczay Z; Horváth Z; Pákáski M: 3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat, Int J Neuropsychopharmacol 10: 183-90, 2007 | Must, A; Juhász A; Rimanóczy Á; Szabó Z; Kéri S; Janka Z: Major depressive disorder, serotonin transporter, and personality traits: Why patients use suboptimal decision-making strategies?, J Affect Disord 103: 273-276, 2007 | Zana M; Janka Z; Kálmán J: Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease, Neurobiol Aging 28: 648-76, 2007 | Kovács ZA; Puskás LG; Juhász A; Rimanóczy Á; Hackler L Jr; Kátay L; Gali Z; Vetró Á; Janka Z; Kálmán J: Hypnosis upregulates the expression of immune-related genes in lymphocytes, Psychother Psychosom 77: 257-9, 2008 | Kéri S; Juhász A; Rimanóczy Á; Szekeres G; Kelemen O; Cimmer C; Szendi I; Benedek G; Janka Z: Habit learning and the genetics of dopamine D3 receptor: Evidence from patients with schizophrenia and healthy controls, Behav Neurosci 119(3): 687-693, 2005 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif) Back »
|
![](img/space.gif) |
|